FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF’s New Video Offers Insights into Multinational Rare Disease Clinical Trials
We are proud to share with you the newly released informative video detailing the challenges and strategies involved in conducting the DEEP- [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was organized by [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise awareness that [...]
Navigating ATMP Submissions to CTIS: Insights from CVBF’s Experts at EUCROF24
On Monday, 19 February 2024, at the EUCROF24 conference in Prague our Head of Development Area, Arianna Bertolani, takes the [...]
New Whitepaper Highlights Potential of Cell Therapy to Revolutionize Faecal Incontinence Treatment
A new whitepaper published on 7 December 2023, in the Journal of Cell and Gene Therapy Insights is bringing attention [...]
Newsletter, December 2023
Newsletter, December 2023 Starting the new year in a larger, more accessible office at Viale Cesare Battisti 17, Pavia [...]
CVBF’s CEO selected as Permanent Member of the Advisory Group of the ACT EU Multistakeholder Platform (MSP AG)
On 20 December 2023, Donato Bonifazi, our CEO, has been selected as a permanent member of the Advisory Group [...]
Newsletter, JULY 2023
11th July 2023 Newsletter, July 2023 We are committed to covering highly unmet medical needs and to providing sponsors with the best research services. We [...]
The EU Health Coalition’s New Manifesto: Paving the Way for a Healthier Europe
The EU Health Coalition, consisting of 47 partners from various sectors across Europe, is dedicated to driving change for a healthier Europe. As a [...]
Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
CVBF collaborated with IRCSS Istituto Clinico Humanitas and Bruschettini Srl on an article published on the Frontiers in Neurology Journal, entitled “Cox regression and survival [...]
CVBF Head of Bio-Statistics lecturer at the Università Campus Bio-Medico di Roma
On 29 April 2023, Giorgio Reggiardo, our experienced research methodologist and biostatistician, held a presentation to the students of the second level master’s degree [...]
-
Clinical Research on Medical Devices. How to maximize the benefit for the patients? – CVBF will tackle the topic of Regulatory Aspects on Medical Devices GalleryClinical Research on Medical Devices. How to maximize the benefit for the patients? – CVBF will tackle the topic of Regulatory Aspects on Medical Devices
Clinical Research on Medical Devices. How to maximize the benefit for the patients? – CVBF will tackle the topic of Regulatory Aspects on Medical Devices
Donato Bonifazi, our CEO, will attend as a speaker, the conference "La ricerca clinica profit e no profit su farmaci e device: Come massimizzare il [...]
CVBF supports the Rare Diseases Day 2023
This 28 February is Rare Diseases Day (RDD), an opportunity to celebrate people living with rare diseases and to raise awareness of these disorders. Donato [...]